Efficacy of Phosphatidylinositol-3 Kinase Inhibitors in a Primary Mouse Model of Undifferentiated Pleomorphic Sarcoma

Table 4

Response rates of BEZ235-treated tumors stratified by initial tumor volume.

	Initial tumor volume		𝑃<0.05	Total
	<250 mm^3	>250 mm^3
BEZ235 tx: complete responders	5/13	1/6	yes	6/19 (32%)
BEZ235 tx: all responders	9/13	2/6	yes	11/19 (58%)